Immunogen reported $-26827000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Agios Pharmaceuticals AGIO:US $ -88.94M 0.07M
Amgen AMGN:US $ 3228M 40M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
Astellas Pharma 4503:JP Y 73000M 19058M
AstraZeneca AZN:LN 2784M 588M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Bristol Myers Squibb BMY:US $ 5712M 33M
Cerulean Pharma CERU:US $ -12.66M 3.51M
Dicerna Pharmaceuticals DRNA:US $ -18.82M 19.76M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Emergent Biosolutions EBS:US $ -1.6M 49.3M
Exelixis EXEL:US $ 56.42M 70.25M
Halozyme Therapeutics HALO:US $ 76.34M 17.51M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Macrogenics MGNX:US $ -50191000 12.69M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Novartis NVS:US $ 4837M 65M
Pfizer PFE:US $ 10235M 2245M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Seattle Genetics SGEN:US $ -281.36M 207.58M